Amgen Revenue 2006-2019 | AMGN

Amgen annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amgen revenue for the quarter ending June 30, 2019 was $5.871B, a 3.1% decline year-over-year.
  • Amgen revenue for the twelve months ending June 30, 2019 was $23.562B, a 1.61% increase year-over-year.
  • Amgen annual revenue for 2018 was $23.747B, a 3.93% increase from 2017.
  • Amgen annual revenue for 2017 was $22.849B, a 0.62% decline from 2016.
  • Amgen annual revenue for 2016 was $22.991B, a 6.14% increase from 2015.
Amgen Annual Revenue
(Millions of US $)
2018 $23,747
2017 $22,849
2016 $22,991
2015 $21,662
2014 $20,063
2013 $18,676
2012 $17,265
2011 $15,582
2010 $15,053
2009 $14,642
2008 $15,003
2007 $14,771
2006 $14,268
2005 $12,430
Amgen Quarterly Revenue
(Millions of US $)
Q2 2019 $5,871
Q1 2019 $5,557
Q4 2018 $6,230
Q3 2018 $5,904
Q2 2018 $6,059
Q1 2018 $5,554
Q4 2017 $5,802
Q3 2017 $5,773
Q2 2017 $5,810
Q1 2017 $5,464
Q4 2016 $5,965
Q3 2016 $5,811
Q2 2016 $5,688
Q1 2016 $5,527
Q4 2015 $5,536
Q3 2015 $5,723
Q2 2015 $5,370
Q1 2015 $5,033
Q4 2014 $5,331
Q3 2014 $5,031
Q2 2014 $5,180
Q1 2014 $4,521
Q4 2013 $5,011
Q3 2013 $4,748
Q2 2013 $4,679
Q1 2013 $4,238
Q4 2012 $4,421
Q3 2012 $4,319
Q2 2012 $4,477
Q1 2012 $4,048
Q4 2011 $3,973
Q3 2011 $3,944
Q2 2011 $3,959
Q1 2011 $3,706
Q4 2010 $3,841
Q3 2010 $3,816
Q2 2010 $3,804
Q1 2010 $3,592
Q4 2009 $3,809
Q3 2009 $3,812
Q2 2009 $3,713
Q1 2009 $3,308
Q4 2008 $3,751
Q3 2008 $3,875
Q2 2008 $3,764
Q1 2008 $3,613
Q4 2007 $3,745
Q3 2007 $3,611
Q2 2007 $3,728
Q1 2007 $3,687
Q4 2006 $3,835
Q3 2006 $3,612
Q2 2006 $3,604
Q1 2006 $3,217
Q4 2005 $3,271
Q3 2005 $3,154
Q2 2005 $3,172
Q1 2005 $2,833
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $123.538B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $81.192B 9.97
Celgene (CELG) United States $67.486B 10.44
Vertex Pharmaceuticals (VRTX) United States $48.089B 51.97
Biogen (BIIB) United States $43.478B 7.72
Illumina (ILMN) United States $42.432B 49.85
CSL (CSLLY) Australia $35.201B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.771B 14.87
Alexion Pharmaceuticals (ALXN) United States $25.266B 13.32
Incyte (INCY) United States $18.177B 53.49
Exact Sciences (EXAS) United States $15.300B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.892B 0.00
Seattle Genetics (SGEN) United States $12.839B 0.00
Genmab (GNMSF) Denmark $12.462B 63.35
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.236B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.141B 0.00
Sarepta Therapeutics (SRPT) United States $8.944B 0.00
Galapagos (GLPG) Belgium $8.582B 0.00
QIAGEN (QGEN) Netherlands $7.850B 25.78
Bio-Techne Corp (TECH) United States $7.344B 50.76
BeiGene (BGNE) Cayman Islands $7.041B 0.00
Exelixis (EXEL) United States $6.861B 17.83
Bluebird Bio (BLUE) United States $6.746B 0.00
Amarin (AMRN) Ireland $5.594B 0.00
Horizon Pharma Public (HZNP) Ireland $5.127B 13.03
Ascendis Pharma (ASND) Denmark $4.875B 0.00
Repligen (RGEN) United States $4.823B 93.60
Moderna (MRNA) United States $4.424B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.419B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.225B 0.00
Blueprint Medicines (BPMC) United States $3.992B 0.00
China Biologic Products (CBPO) China $3.912B 24.42
Spark Therapeutics (ONCE) United States $3.888B 0.00
MorphoSys AG (MOR) Germany $3.874B 0.00
Mirati Therapeutics (MRTX) United States $3.624B 0.00
Alkermes (ALKS) Ireland $3.469B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.426B 0.00
Immunomedics (IMMU) United States $2.849B 0.00
Arena Pharmaceuticals (ARNA) United States $2.822B 6.06
Genomic Health (GHDX) United States $2.768B 51.90
Amicus Therapeutics (FOLD) United States $2.676B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.656B 0.00
NeoGenomics (NEO) United States $2.649B 141.72
Medicines (MDCO) United States $2.633B 0.00
MyoKardia (MYOK) United States $2.536B 0.00
Acceleron Pharma (XLRN) United States $2.450B 0.00
Halozyme Therapeutics (HALO) United States $2.440B 0.00
Reata Pharmaceuticals (RETA) United States $2.358B 0.00
Emergent Biosolutions (EBS) United States $2.279B 34.23
Intercept Pharmaceuticals (ICPT) United States $2.165B 0.00
UniQure (QURE) Netherlands $2.152B 0.00
Akcea Therapeutics (AKCA) United States $2.042B 0.00
Cambrex (CBM) United States $1.993B 25.20
Zai Lab (ZLAB) China $1.976B 0.00
Myriad Genetics (MYGN) United States $1.853B 19.44
Ligand Pharmaceuticals (LGND) United States $1.846B 23.34
Denali Therapeutics (DNLI) United States $1.803B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.621B 0.00
Insmed (INSM) United States $1.506B 0.00
REGENXBIO (RGNX) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.375B 0.00
RA PHARMCTL INC (RARX) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.342B 0.00
AnaptysBio (ANAB) United States $1.321B 0.00
Editas Medicine (EDIT) United States $1.277B 0.00
Epizyme (EPZM) United States $1.262B 0.00
Fate Therapeutics (FATE) United States $1.242B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.227B 0.00
Athenex (ATNX) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.204B 0.00
Innoviva (INVA) United States $1.173B 3.39
Alector (ALEC) United States $1.083B 0.00
Zymeworks (ZYME) Canada $0.989B 0.00
Twist Bioscience (TWST) United States $0.988B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Cara Therapeutics (CARA) United States $0.945B 0.00
Principia Biopharma (PRNB) United States $0.941B 490.63
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.847B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.842B 0.00
Adverum Biotechnologies (ADVM) United States $0.833B 0.00
Cytokineticsorporated (CYTK) United States $0.821B 0.00
ANI Pharmaceuticals (ANIP) United States $0.817B 13.64
Vanda Pharmaceuticals (VNDA) United States $0.817B 29.48
Alder BioPharmaceuticals (ALDR) United States $0.813B 0.00
Arvinas (ARVN) United States $0.807B 0.00
Anika Therapeutics (ANIK) United States $0.792B 28.03
Codexis (CDXS) United States $0.769B 0.00
Retrophin (RTRX) United States $0.762B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Vericel (VCEL) United States $0.757B 0.00
WAVE Life Sciences (WVE) Singapore $0.745B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Stemline Therapeutics (STML) United States $0.663B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.650B 0.00
Zealand Pharma (ZEAL) Denmark $0.640B 7.42
MiMedx (MDXG) United States $0.611B 0.00
Heska (HSKA) United States $0.576B 74.64
DBV Technologies S.A (DBVT) France $0.552B 0.00
Cellectis S.A (CLLS) France $0.537B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Revance Therapeutics (RVNC) United States $0.503B 0.00
Intra-Cellular Therapies (ITCI) United States $0.501B 0.00
PHARMA MAR SA (PHMMF) Spain $0.501B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
Syros Pharmaceuticals (SYRS) United States $0.474B 0.00
Mesoblast (MESO) Australia $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.459B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.436B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.434B 0.00
CytomX Therapeutics (CTMX) United States $0.434B 0.00
Merus (MRUS) Netherlands $0.422B 0.00
BioDelivery Sciences (BDSI) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.397B 0.00
Agenus (AGEN) United States $0.390B 0.00
AC Immune SA (ACIU) Switzerland $0.387B 28.65
AMAG Pharmaceuticals (AMAG) United States $0.379B 0.00
Avid Bioservices (CDMO) United States $0.374B 0.00
Gritstone Oncology (GRTS) United States $0.352B 0.00
Scholar Rock Holding (SRRK) United States $0.343B 0.00
Kadmon Holdings (KDMN) United States $0.333B 0.00
Arcus Biosciences (RCUS) United States $0.331B 0.00
Clovis Oncology (CLVS) United States $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Albireo Pharma (ALBO) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.316B 0.00
Prothena (PRTA) Ireland $0.315B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Cel-Sci (CVM) United States $0.302B 0.00
Sorrento Therapeutics (SRNE) United States $0.301B 0.00
Protagonist Therapeutics (PTGX) United States $0.290B 0.00
Kindred Biosciences (KIN) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.286B 7.35
Dynavax Technologies (DVAX) United States $0.282B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.274B 0.00
Geron (GERN) United States $0.266B 0.00
Senesco Technologies (ELOX) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Cellular Biomedicine (CBMG) United States $0.241B 0.00
Inovio Pharmaceuticals (INO) United States $0.241B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.237B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
Seres Therapeutics (MCRB) United States $0.231B 0.00
Prometic Life Sciences (PFSCF) Canada $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.229B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
MannKind (MNKD) United States $0.222B 0.00
Pfenex (PFNX) United States $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.216B 0.00
Kamada (KMDA) Israel $0.216B 8.26
PHASEBIO PHARMA (PHAS) United States $0.215B 0.00
Athersys (ATHX) United States $0.205B 0.00
Sutro Biopharma (STRO) United States $0.203B 0.00
Compugen (CGEN) Israel $0.200B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
Palatin Technologies (PTN) United States $0.195B 0.00
Cue Biopharma (CUE) United States $0.187B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Affimed (AFMD) Germany $0.177B 0.00
Novavax (NVAX) United States $0.174B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.161B 0.00
Emmaus Life Sciences (EMMA) United States $0.161B 0.00
Cerecor (CERC) United States $0.160B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Alcobra (ARCT) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
XOMA (XOMA) United States $0.155B 0.00
Synlogic (SYBX) United States $0.153B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.150B 0.00
BioTime (LCTX) United States $0.150B 9.99
Strongbridge Biopharma (SBBP) United States $0.149B 6.11
Enzo Biochem (ENZ) United States $0.148B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Acorda Therapeutics (ACOR) United States $0.141B 0.00
Adocia (ADOCY) France $0.140B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Northwest Biotherapeutics (NWBO) United States $0.115B 0.00
TOCAGEN INC (TOCA) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.110B 0.00
Aduro Biotech (ADRO) United States $0.110B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.107B 0.00
Liquidia Technologies (LQDA) United States $0.105B 0.00
Aptinyx (APTX) United States $0.104B 0.00
OvaScience (MLND) United States $0.098B 0.00
Verastem (VSTM) United States $0.096B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Menlo Therapeutics (MNLO) United States $0.091B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Trevena (TRVN) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Antibe Therapeutics (ATBPF) Canada $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Curis (CRIS) United States $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
VBI Vaccines (VBIV) United States $0.064B 0.00
Unum Therapeutics (UMRX) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 31.80
Prima BioMed (IMMP) Australia $0.058B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.054B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.049B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Signal Genetics (MGEN) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.031B 0.21
DiaMedica Therapeutics (DMAC) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Soligenix (SNGX) United States $0.021B 0.00
Vical (VICL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.27
Bionano Genomics (BNGO) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
AmpliPhi Biosciences (ARMP) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00